Clinical Trial Update: Continuous Infusion of Campath-1H Followed by Subcutaneous Injections in Previously Treated Patients With Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of continuous infusion Campath-1H (alemtuzumab) followed by subcutaneous injections in previously treated chronic lymphocytic leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Campath-1H (alemtuzumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED